Your browser doesn't support javascript.
loading
Microarray-Based CD38 Peptide Probe Screening for Multiple Myeloma Imaging.
Li, Xuejie; Wang, Yuanzhuo; Yang, Qi; Song, Lele; Kang, Lei; Hu, Zhiyuan; Wang, Zihua.
Afiliación
  • Li X; Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, China.
  • Wang Y; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
  • Yang Q; CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
  • Song L; Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
  • Kang L; Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
  • Hu Z; Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
  • Wang Z; Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, China.
Mol Pharm ; 21(1): 245-254, 2024 Jan 01.
Article en En | MEDLINE | ID: mdl-38096423
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Animals Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Límite: Animals Idioma: En Revista: Mol Pharm Asunto de la revista: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: China